1-13 of 13
Andrew J Klink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAR T Therapy Referral for Diffuse Large B Cell Lymphoma (DLBCL) By U.S. Community Hematology/Oncology (cH/O) Practices: Perceptions and Patterns

David L Porter, Andrew J Klink, Alexandrina Balanean, Lindsay McAllister, Bruce A. Feinberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4977.
https://doi.org/10.1182/blood-2021-151807
Published: 2021
Journal Articles

Real-World Treatment of Patients with Large B-Cell Lymphoma in the United States with Chimeric Antigen Receptor T-Cell Therapy

Kristin M. Zimmerman Savill, Andrew J Klink, Djibril Liassou, Dhruv Chopra, Jalyna Laney, Ajeet Gajra
Journal: Blood
Blood (2021) 138 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2021-150723
Published: 2021
Journal Articles

Real-World Use of Enasidenib in Relapsed or Refractory Acute Myeloid Leukemia Is Associated with Reduced Risk of Disease Progression and Death

Andrew J Klink, PhD MPH, Ronda Copher, PhD, Russell L. Knoth, Landon Marshall, PharmD, PhD, Ying Hou, MD, Ajeet Gajra, MD MBBS, Raoul Tibes, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18.
https://doi.org/10.1182/blood-2020-140005
Published: 2020
Journal Articles

Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) Associated with PARP Inhibitors: A Real-World Analysis

Ajeet Gajra, MD MBBS, Marjorie E Zettler, PhD MPH, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142069
Published: 2020
Journal Articles

Real-World Effectiveness of First-Line (1L) Dasatinib Versus 1L Imatinib in Newly Diagnosed Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML)

Andrew J Klink, PhD MPH, Scott Justin Keating, MS, John Brokars, MS, Arianna Kee, Ronda Copher, PhD, Brian Stwalley, PharmD BCGP, Bruce Feinberg, DO, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-141125
Published: 2020
Journal Articles

Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among U.S. Community Hematologists/ Oncologists (cH/O)

Ajeet Gajra, MD MBBS, Yamini S Rathish, Yolaine Jeune-Smith, PhD, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-142005
Published: 2020
Journal Articles

Real-World Analysis of Adverse Events Associated with CAR T-Cell Therapy Among Adults Age ≥65 Years

Marjorie E Zettler, PhD MPH, Bruce A Feinberg, DO, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Sonam Mehta, Ajeet Gajra, MD FACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 1951.
https://doi.org/10.1182/blood-2019-127372
Published: 2019
Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 1952.
https://doi.org/10.1182/blood-2019-129593
Published: 2019
Journal Articles

Utilization of Immune Checkpoint Inhibitors for Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) in Oncology Community Practices

Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Chadi Nabhan, MDMBA, FACP, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 4057.
https://doi.org/10.1182/blood-2019-129632
Published: 2019
Journal Articles

Real-World Utilization of Midostaurin Among Patients with Acute Myeloid Leukemia (AML)

Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Dhruv Chopra, MS, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 5135.
https://doi.org/10.1182/blood-2019-130671
Published: 2019
Journal Articles

Real-World Utilization of Midostaurin Among Patients with Systemic Mastocytosis (SM)

Ajeet Gajra, MD FACP, Andrew J Klink, PhD MPH, Dhruv Chopra, MS, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 5378.
https://doi.org/10.1182/blood-2019-131028
Published: 2019
Journal Articles

Treatment Patterns and Outcomes of Relapsed/Refractory Peripheral T-Cell Lymphoma (RR-PTCL) Patients Treated in the Community Oncology Setting

Chadi Nabhan, MD, Jalyna Laney, RN, Joseph Feliciano, PharmD, Choo Hyung Lee, MA, MS, Andrew J Klink, PhD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 1656.
https://doi.org/10.1182/blood-2018-99-115437
Published: 2018
Journal Articles

Treatment Sequence of Lenalidomide (LEN) and Hypomethylating Agents (HMAs) and the Impact on Clinical Outcomes for Patients with Myelodysplastic Syndromes (MDS)

Amer M. Zeidan, MD, Andrew J Klink, PhD MPH, Bruce Feinberg, DO, Michael McGuire, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2188.
https://doi.org/10.1182/blood.V130.Suppl_1.2188.2188
Published: 2017